Legal & General Group
CYTR

Legal & General Group’s CytRx Corp CYTR Stock Holding History

Legal & General Group’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,940
Closed -$15K – 3470
2017
Q1 		$15K Hold
5,940
– – ﹤0.01% 3149
2016
Q4 		$14K Buy
5,940
+3,888
+189% +$11.4K ﹤0.01% 3179
2016
Q3 		$7K Hold
2,052
– – ﹤0.01% 2862
2016
Q2 		$27K Buy
+2,052
New +$34.1K ﹤0.01% 2789

Other funds holding CYTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Legal & General Group's CYTR Position: Q2 2017 in Review

Legal & General Group sold out of CytRx Corp (CYTR) in Q2 2017, closing a stake of 5,940 shares — an estimated $15K sold.

Legal & General Group first reported a position in CYTR in Q2 2016 and held it in 4 quarters. The position peaked at $27K in Q2 2016. 54 funds tracked by Wall St. Rank hold CYTR as of Q2 2017.

  • Legal & General Group reported no remaining CytRx Corp position as of Q2 2017 after selling out during the quarter.
  • Legal & General Group sold 5,940 CytRx Corp shares in Q2 2017, an estimated $15K.
  • Legal & General Group first reported a position in CytRx Corp in Q2 2016 and held it in 4 quarters.
  • Legal & General Group's CytRx Corp position peaked at $27K in Q2 2016.
  • 54 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2017.

Based on Legal & General Group's 13F filing for Q2 2017, filed 3 Aug 2017.